Oncogene

SJR Rank #991H-index: 387SJR: 2.474Best quartile: Q1Open AccessAPC: US$5,990
Journal website: aims, scope and author guidelines
Publisher

Springer Nature

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.651.31.952.6

Subject Categories

  • Cancer ResearchQ1
  • GeneticsQ1
  • Molecular BiologyQ1

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Cancer-related Molecular PathwaysEpigenetics and DNA MethylationRNA modifications and cancerUbiquitin and proteasome pathwaysCell death mechanisms and regulationCancer-related gene regulationDNA Repair MechanismsRNA Research and SplicingCancer, Hypoxia, and MetabolismPI3K/AKT/mTOR signaling in cancer

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250150300450600

Detailed Information

ISSN

1476-5594, 0950-9232

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

7.92

References per Document

53.49

Coverage

1987-2026

Scope

Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.

Metrics from SCImago Journal Rank 2025. View on SCImago